Literature DB >> 21984657

Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database.

Hermann Brenner1, Lutz Altenhofen, Alexander Katalinic, Iris Lansdorp-Vogelaar, Michael Hoffmeister.   

Abstract

The sojourn time of preclinical colorectal cancer is a critical parameter in modeling effectiveness and cost-effectiveness of colorectal cancer screening. For ethical reasons, it cannot be observed directly, and available estimates are based mostly on relatively small historic data sets that do not include differentiation by age and sex. The authors derived sex- and age-specific estimates (age groups: 55-59, 60-64, 65-69, 70-74, 75-79, and ≥80 years) of mean sojourn time, combining data from the German national screening colonoscopy registry (based on 1.88 million records) and data from population-based cancer registries (population base: 37.9 million people) for the years 2003-2006. Estimates of mean sojourn time were similar for both sexes and all age groups and ranged from 4.5 years (95% confidence interval: 4.1, 4.8) to 5.8 years (95% confidence interval: 5.3, 6.3) for the subgroups assessed. Sensitivity analyses indicated that mean sojourn time might be approximately 1.5 years longer if colorectal cancer prevalence in nonparticipants of screening colonoscopy is 20% lower than prevalence in participants or 1 year shorter if it exceeds the prevalence in participants by 20%. This study provides, for the first time, precise estimates of sojourn time by age and sex, and it suggests that sojourn times are remarkably consistent across age groups and in both sexes.

Entities:  

Mesh:

Year:  2011        PMID: 21984657     DOI: 10.1093/aje/kwr188

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

Review 1.  Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.

Authors:  Tobias Niedermaier; Korbinian Weigl; Michael Hoffmeister; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-06-30       Impact factor: 8.082

2.  The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.

Authors:  Marjolein J E Greuter; Johannes Berkhof; Remond J A Fijneman; Erhan Demirel; Jie-Bin Lew; Gerrit A Meijer; Jaap Stoker; Veerle M H Coupé
Journal:  Br J Radiol       Date:  2016-05-19       Impact factor: 3.039

Review 3.  Interval colorectal cancers: what and why.

Authors:  Chantal M C le Clercq; Silvia Sanduleanu
Journal:  Curr Gastroenterol Rep       Date:  2014-03

4.  Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.

Authors:  Reinier G S Meester; Ann G Zauber; Chyke A Doubeni; Christopher D Jensen; Virginia P Quinn; Mark Helfand; Jason A Dominitz; Theodore R Levin; Douglas A Corley; Iris Lansdorp-Vogelaar
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-19       Impact factor: 11.382

5.  Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.

Authors:  Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Miguel A Hernán; Eline Aas; Tor J Eide; Eva Skovlund; Jon Lekven; Jörn Schneede; Kjell Magne Tveit; Morten Vatn; Giske Ursin; Geir Hoff
Journal:  Ann Intern Med       Date:  2018-04-24       Impact factor: 25.391

6.  Prevention of Advanced Cancer by Vitamin D3 Supplementation: Interaction by Body Mass Index Revisited.

Authors:  Hermann Brenner; Sabine Kuznia; Clarissa Laetsch; Tobias Niedermaier; Ben Schöttker
Journal:  Nutrients       Date:  2021-04-22       Impact factor: 5.717

7.  A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer.

Authors:  Per Jess; Iben Onsberg Hansen; Michael Gamborg; Tine Jess
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

Review 8.  Framework and Strategies to Eliminate Disparities in Colorectal Cancer Screening Outcomes.

Authors:  Chyke A Doubeni; Kevin Selby; Samir Gupta
Journal:  Annu Rev Med       Date:  2020-11-18       Impact factor: 13.739

9.  Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model.

Authors:  Mary Linton B Peters; Andrew Eckel; Peter P Mueller; Angela C Tramontano; Davis T Weaver; Anna Lietz; Chin Hur; Chung Yin Kong; Pari V Pandharipande
Journal:  Pancreatology       Date:  2018-07-29       Impact factor: 3.977

10.  Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.

Authors:  Szu-Min Peng; Wen-Feng Hsu; Ying-Wei Wang; Li-Ju Lin; Amy Ming-Fang Yen; Li-Sheng Chen; Yi-Chia Lee; Ming-Shiang Wu; Tony Hsiu-Hsi Chen; Han-Mo Chiu
Journal:  Gut       Date:  2020-09-28       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.